Tubular carcinomas of the breast: an epidemiologic study

Author:

Sun Jia-Yuan1,Zhou Juan2,Zhang Wen-Wen1,Li Feng-Yan1,He Zhen-Yu1,Wu San-Gang3

Affiliation:

1. Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, PR China

2. Department of Obstetrics & Gynecology, the First Affiliated Hospital of Xiamen University, Xiamen 361003, PR China

3. Department of Radiation Oncology, Xiamen Cancer Hospital, the First Affiliated Hospital of Xiamen University, Xiamen 361003, PR China

Abstract

Aim: We explored the clinicopathologic characteristics, prognostic factors and outcomes in tubular carcinoma (TC) of the breast. Methods: We retrospectively assessed 8091 TC patients using the SEER database from 2000 to 2013. Results: Most patients were non-Hispanic white, well-differentiated disease, tumor size ≤2 cm, node-negative, nonmetastatic, hormone receptor-positive and HER2-negative status. The 10-year breast cancer-specific survival and overall survival were 98.1 and 82.0%, respectively. Multivariate analysis indicated that age, ethnicity, surgery procedures, radiotherapy and chemotherapy were independent predictors affecting survival outcomes. There was comparable breast cancer-specific survival between surgery and nonsurgery groups. Conclusion: The patients with TC has excellent survival outcomes, which may in part be due to the favorable tumor characteristics.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Reference32 articles.

1. Kempson R. Stanford school of medicine surgical pathology criteria: tubular carcinoma of the breast (2008). http://surgpathcriteria.stanford.edu/breast/tubularcabr.

2. Tavassoli F, Devilee P. Pathology and genetics tumours of breast and female genital organs. IARC Press, Lyon, France (2003).

3. Tumor Characteristics and Clinical Outcome of Tubular and Mucinous Breast Carcinomas

4. Tubular Carcinoma of the Breast: Further Evidence to Support Its Excellent Prognosis

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3